Related Experiment Video
Updated: Jun 20, 2026
08:42
Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China
Published on: February 11, 2022
Directional coronary atherectomy: a time for reflection. Should we let it go?
Roberto J Cubeddu1, Quynh A Truong, Pablo Rengifo-Moreno
1Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Summary
Directional coronary atherectomy (DCA) offers unique benefits for complex coronary procedures and in vivo tissue examination. Despite past controversies, its continued use as a niche device is advocated for patient well-being.
Area of Science:
- Cardiovascular Interventions
- Interventional Cardiology
- Medical Device Technology
Background:
- Percutaneous coronary angioplasty has led to numerous interventional tools, with varying clinical adoption.
- Directional coronary atherectomy (DCA), developed in 1984, aimed to overcome balloon angioplasty limitations but faced challenges.
- DCA's usage has declined, with many centers no longer offering the device.
Purpose of the Study:
- To review the evolution and clinical utility of directional coronary atherectomy (DCA).
- To highlight DCA's potential as a lesion-specific niche device for complex coronary interventions.
- To emphasize DCA's unique role in in vivo pathological coronary tissue examination for research.
Main Methods:
- Review of the historical development and application of directional coronary atherectomy.
- Presentation of complex percutaneous coronary procedures demonstrating DCA's utility.
- Discussion of DCA's value in pathological tissue analysis.
Main Results:
- Directional coronary atherectomy (DCA) provides a distinct approach for specific complex coronary lesions.
- DCA facilitates in vivo examination of coronary tissue pathology, offering research insights.
- Despite historical setbacks, DCA remains a valuable tool in select interventional scenarios.
Conclusions:
- Directional coronary atherectomy (DCA) should be preserved as a niche interventional device.
- Continued production and use of DCA are recommended for specific patient care and research.
- DCA's unique capabilities warrant its retention in the interventional cardiology armamentarium.
Related Concept Videos
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:27Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
01:27Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
01:26Coronary Artery Disease IV: Preventive Measures
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
01:26Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
01:25Aortic Regurgitation III: Medical Management
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...